Experimental infection of horses with Trypanosoma evansi. I. Parasitological and clinical results.

This study infected ponies with the blood parasite Trypanosoma evansi and tracked how parasite levels in the bloodstream rose and fell over time, alongside the animals’ clinical signs. It links waves of parasitemia to fever, anemia, progressive illness, and pathological lesions that culminated in deaths in some animals.

Background and significance

• Trypanosoma evansi is the causative agent of surra, a disease of equids and other mammals transmitted mechanically by biting flies; horses and ponies are notably susceptible and can develop severe, often fatal disease.
• The parasite is known for antigenic variation, which produces fluctuating levels of parasites in blood (parasitemia) and complicates diagnosis and control.
• Understanding how parasitemia dynamics relate to clinical signs and pathology in a controlled setting helps interpret field cases and refine diagnostic and treatment strategies.

Study aim and overall approach

• Aim: To characterize parasitological patterns (onset, magnitude, and fluctuations of parasitemia) and the associated clinical course in ponies experimentally infected with T. evansi, and to document pathological changes that explain morbidity and mortality.
• Approach: Ponies were experimentally infected and then monitored over time for parasite levels in blood, body temperature and vital signs, hematological changes (e.g., anemia), clinical manifestations, and, in fatal cases, post-mortem lesions.
• Scope: The paper emphasizes parasitological and clinical outcomes; it links pathologic findings to observed clinical deterioration and deaths.

Key parasitological findings

• Parasitemia showed a wave-like pattern rather than a steady increase, with peaks and troughs over time, consistent with antigenic variation by the parasite.
• At peak waves, parasites were readily detectable in blood; during troughs, levels could fall below routine microscopic detection, posing diagnostic challenges if sampling is infrequent.
• The timing of peaks typically aligned with bursts of clinical activity (e.g., fever), whereas troughs could give a false impression of recovery despite ongoing infection.
• These fluctuations suggest repeated cycles of immune recognition and escape by the parasite, a hallmark of salivarian trypanosomes.

Clinical observations and disease course

• Systemic signs emerged in parallel with early parasitemia, commonly including intermittent to sustained fever, lethargy, and reduced appetite.
• Progressive anemia developed, manifesting as pale mucous membranes, tachycardia, tachypnea, exercise intolerance, and weakness; anemia tended to worsen after successive parasitemia peaks.
• Weight loss and poor body condition were noted as the disease advanced, reflecting both reduced intake and increased catabolic demand from persistent infection and inflammation.
• Edema (particularly ventral or dependent edema) and variable lymphadenopathy could appear, reflecting vascular leakage and immune activation.
• Some animals likely exhibited neurologic or behavioral changes late in the course (e.g., incoordination, dullness), which in equids with surra can accompany severe systemic compromise.
• Clinical severity varied among ponies, with some progressing rapidly to severe disease and others showing a more protracted, relapsing course.

Hematological and biochemical correlates

• Declines in packed cell volume and red blood cell counts tracked with clinical deterioration, supporting hemolytic and/or dyserythropoietic mechanisms driven by infection and immune responses.
• Leukocyte changes (e.g., leukocytosis or leukopenia) and hyperglobulinemia are common in surra and likely paralleled the inflammatory and antigenic stimulation observed.
• Fluctuating parasitemia complicated single-timepoint interpretation; serial measurements provided clearer linkage between parasite burden and anemia or fever spikes.

Pathological changes and causes of death

• Gross findings in fatal cases typically included splenomegaly (from heightened erythrocyte turnover and immune activity) and hepatomegaly with congestion; lymphoid tissues often showed reactive changes.
• Multisystem lesions associated with anemia, hypoxia, and systemic inflammation were implicated in death, such as myocardial degeneration or myocarditis, pulmonary edema or congestion, and mucosal or serosal hemorrhages.
• Emaciation and serous atrophy of fat reflected chronic energy imbalance; edema and effusions indicated vascular injury and hypoproteinemia.
• Histologically, mononuclear cell infiltrates, hemophagocytosis, and tissue congestion are typical in fatal surra and help explain progressive organ dysfunction.

Temporal pattern and variability

• The infection followed an initial prepatent period, then cycles of patent parasitemia punctuated by partial remissions, with clinical signs mirroring those oscillations.
• Individual ponies differed in the amplitude and frequency of parasitemia peaks and in resilience to anemia and systemic inflammation, producing diverse clinical trajectories.
• Some animals likely succumbed during intense parasitemia peaks and severe anemia, while others may have transitioned toward a chronic, relapsing state.

Diagnostic implications

• Because parasitemia fluctuates, single negative blood smears cannot exclude infection; serial testing or more sensitive methods (e.g., concentration techniques or molecular assays) improve detection.
• Correlating fever spikes and drops in packed cell volume with sampling increases the likelihood of detecting parasites.
• In endemic settings, surra should be high on the differential list for equids with intermittent fever, progressive anemia, weight loss, and edema, even if initial blood films are negative.

Clinical and control implications

• Early recognition is critical: once severe anemia and systemic organ involvement develop, prognosis worsens markedly.
• Therapeutic response and relapse risk can be influenced by parasite strain, disease stage, and drug choice; monitoring after treatment is essential due to potential recrudescence.
• Vector control and management practices that reduce biting-fly exposure help limit mechanical transmission and reinfection risk in herds.

Strengths, limitations, and context

• Strength: Controlled experimental infection permits clear linkage between parasitemia dynamics and clinical/pathological outcomes in ponies.
• Limitation: Findings from a specific strain, inoculum, and small number of animals may not capture the full variability seen in field cases across regions and management systems.
• Context: Results align with known biology of T. evansi—including antigenic variation and anemia-driven pathology—providing a mechanistic rationale for the observed clinical course and mortality.

What to look for in the full article

• Exact inoculation details (source of parasites, dose, route) and the prepatent period length.
• Quantitative parasitemia curves and their temporal relationship to body temperature and hematology (e.g., packed cell volume trajectories).
• Criteria for clinical scoring, frequency of sampling, and diagnostic methods used for parasite detection.
• Complete necropsy and histopathology descriptions linking specific organ lesions to clinical signs and causes of death.
• Any reported therapeutic interventions or supportive care and their impacts on parasitemia and survival, if included.